# Griseofulvin

NDC: 0472-0013
Generic name: Griseofulvin
Labeler / Manufacturer: Actavis Pharma, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: SUSPENSION
Routes: ORAL
Marketing started: 20070726

FDA application: ANDA065394

## Active ingredients

- GRISEOFULVIN: 125 mg/5mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0472-0013"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0472-0013
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=af318d5d-cc39-4a63-a590-b87c50f2694f